UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reference interval establishment and correlation research of urine thromboxane metabolites: Unveiling new possibilities in platelet activation

Clinica chimica acta, 2024-05, Vol.558, p.119672-119672, Article 119672

2024

Volltextzugriff (PDF)

Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation

Journal of the American College of Cardiology, 2017-09, Vol.70 (12), p.1455-1462

2017

Volltextzugriff (PDF)

Reversal of the anti‐platelet effects of aspirin and clopidogrel

Journal of thrombosis and haemostasis, 2012-04, Vol.10 (4), p.521-528

2012

Volltextzugriff (PDF)

Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid : Determinants and Effect on Cardiovascular Risk

Circulation (New York, N.Y.), 2008-10, Vol.118 (17), p.1705-1712

2008

Volltextzugriff (PDF)

Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis

European journal of clinical pharmacology, 2021-12, Vol.77 (12), p.1815-1823

2021

Volltextzugriff (PDF)

The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy

Blood, 2010-02, Vol.115 (5), p.1054-1061

2010

Volltextzugriff (PDF)

Evaluation of dose-related effects of aspirin on platelet function : Results from the aspirin-induced platelet effect (ASPECT) study

Circulation (New York, N.Y.), 2007-06, Vol.115 (25), p.3156-3164

2007

Volltextzugriff (PDF)

The intake of broccoli sprouts modulates the inflammatory and vascular prostanoids but not the oxidative stress-related isoprostanes in healthy humans

Food chemistry, 2015-04, Vol.173, p.1187-1194

2015

Volltextzugriff (PDF)

Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study

The journals of gerontology. Series A, Biological sciences and medical sciences, 2012-06, Vol.67 (6), p.671-676

2012

Volltextzugriff (PDF)

Untargeted metabolomics reveals alterations in metabolites of lipid metabolism and immune pathways in the serum of rats after long-term oral administration of Amalaki rasayana

Molecular and cellular biochemistry, 2020-01, Vol.463 (1-2), p.147-160

2020

Volltextzugriff (PDF)

Association of cyclooxygenase-2 genetic variant with cardiovascular disease

European heart journal, 2014-09, Vol.35 (33), p.2242-2248

2014

Volltextzugriff (PDF)

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

Circulation (New York, N.Y.), 2002-04, Vol.105 (14), p.1650-1655

2002

Volltextzugriff (PDF)

Urinary 11-dehydro-thromboxane B2 levels are associated with vascular inflammation and prognosis in atherosclerotic cardiovascular disease

Prostaglandins & other lipid mediators, 2018-01, Vol.134, p.24-31

2018

Volltextzugriff (PDF)

Urinary 11-Dehydro-Thromboxane B 2 and Mortality in Patients With Stable Coronary Artery Disease

The American journal of cardiology, 2017-04, Vol.119 (7), p.972-977

2017

Volltextzugriff (PDF)

Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation

The American heart journal, 2015-09, Vol.170 (3), p.490-497.e1

2015

Volltextzugriff (PDF)

Reduced Variability to Aspirin Antiplatelet Effect by the Coadministration of Statins in High‐Risk Patients for Cardiovascular Disease

Clinical pharmacology and therapeutics, 2018-07, Vol.104 (1), p.111-119

2018

Volltextzugriff (PDF)

Aging‐Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation

Journal of the American Heart Association, 2016-09, Vol.5 (9), p.n/a

2016

Volltextzugriff (PDF)

Antiplatelet Effect Durability of a Novel, 24-hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus

The American journal of cardiology, 2016-12, Vol.118 (12), p.1941-1947

2016

Volltextzugriff (PDF)

Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding

Pharmacological research, 2016-11, Vol.113 (Pt A), p.484-489

2016

Volltextzugriff (PDF)

Oxidative stress reflected by increased F 2 -isoprostanes is associated with increasing urinary 11-dehydro thromboxane B 2 levels in patients with coronary artery disease

Thrombosis research, 2016-12, Vol.148, p.85

2016

Volltextzugriff (PDF)

Effects of immunosuppressive agents on the hemostatic system in normal dogs

Journal of veterinary internal medicine, 2018-07, Vol.32 (4), p.1325-1333

2018

Volltextzugriff (PDF)

Systemic Biosynthesis of Prostacyclin by Cyclooxygenase (COX)-2: The Human Pharmacology of a Selective Inhibitor of COX-2

Proceedings of the National Academy of Sciences - PNAS, 1999-01, Vol.96 (1), p.272-277

1999

Volltextzugriff (PDF)

Mediterranean diet reduces thromboxane A2 production in atrial fibrillation patients

Clinical nutrition (Edinburgh, Scotland), 2015-10, Vol.34 (5), p.899-903

2015

Volltextzugriff (PDF)

Intermittent hypoxia-activated cyclooxygenase pathway: role in atherosclerosis

The European respiratory journal, 2013-08, Vol.42 (2), p.404-413

2013

Volltextzugriff (PDF)

1 – 25 von 661

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(587)
Mit Volltextzugriff
(491)

Publikationsform

Artikel
(661)

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(481)
Life Sciences & Biomedicine
(474)
Humans
(436)
Female
(395)
Thromboxane B2 - Analogs & Derivatives
(366)
Thromboxane B2 - Urine
(336)
Biological And Medical Sciences
(329)
Medical Sciences
(273)
Middle Aged
(260)
Adult
(253)
Animals
(252)
Thromboxane B2 - Blood
(212)
Aged
(188)
Cardiovascular System & Cardiology
(150)
Rats
(123)
Pharmacology. Drug Treatments
(119)
Platelet Aggregation - Drug Effects
(119)
Thromboxane B2 - Metabolism
(102)
Peripheral Vascular Disease
(95)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Reference interval establishment and correlation research of urine thromboxane metabolites: Unveiling new possibilities in platelet activation

Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation

Reversal of the anti‐platelet effects of aspirin and clopidogrel

Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid : Determinants and Effect on Cardiovascular Risk

Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis

The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy

Evaluation of dose-related effects of aspirin on platelet function : Results from the aspirin-induced platelet effect (ASPECT) study

The intake of broccoli sprouts modulates the inflammatory and vascular prostanoids but not the oxidative stress-related isoprostanes in healthy humans

Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study

Untargeted metabolomics reveals alterations in metabolites of lipid metabolism and immune pathways in the serum of rats after long-term oral administration of Amalaki rasayana

Association of cyclooxygenase-2 genetic variant with cardiovascular disease

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

Urinary 11-dehydro-thromboxane B2 levels are associated with vascular inflammation and prognosis in atherosclerotic cardiovascular disease

Urinary 11-Dehydro-Thromboxane B 2 and Mortality in Patients With Stable Coronary Artery Disease

Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation

Reduced Variability to Aspirin Antiplatelet Effect by the Coadministration of Statins in High‐Risk Patients for Cardiovascular Disease

Aging‐Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation

Antiplatelet Effect Durability of a Novel, 24-hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus

Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding

Oxidative stress reflected by increased F 2 -isoprostanes is associated with increasing urinary 11-dehydro thromboxane B 2 levels in patients with coronary artery disease

Effects of immunosuppressive agents on the hemostatic system in normal dogs

Systemic Biosynthesis of Prostacyclin by Cyclooxygenase (COX)-2: The Human Pharmacology of a Selective Inhibitor of COX-2

Mediterranean diet reduces thromboxane A2 production in atrial fibrillation patients

Intermittent hypoxia-activated cyclooxygenase pathway: role in atherosclerosis

Cardiovascular events occur independently of high on-aspirin platelet reactivity and residual COX-1 activity in stable cardiovascular patients

Aktive Filter

Suchergebnisse filtern